Skip to main content
. 2022 Mar 15;26:101484. doi: 10.1016/j.ajoc.2022.101484

Fig. 2.

Fig. 2

A & B. Computed tomography of the orbits 42 weeks after completion of teprotumumab demonstrating recurrence of extraocular muscle enlargement and proptosis. C. External photograph taken at 33 weeks after completion of teprotumumab, when the patient presented with disease recurrence. D. External photograph taken 1 week after bilateral medial and lateral wall decompression surgeries.